Spruce Biosciences, Inc.
SPRB
Revenue
1.61M
▼-392.00k▼-19.58%
3 Months ChangeAssets
75.52M
▼-12.02M▼-13.73%
3 Months ChangeLiabilities
16.35M
▼-4.57M▼-21.83%
3 Months ChangeFree Cash Flow
-8.81M
▼-8.81M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0000950170-24-117786
2024-08-12
Form 10-Q
ID: 0000950170-24-095461
2024-08-12
Form 8-K
ID: 0000950170-24-095417
2024-06-18
Form 8-K
ID: 0000950170-24-074990
2024-06-03
Form 8-K
ID: 0000950170-24-067650
2024-05-24
Form 8-K
ID: 0000950170-24-064561
2024-05-13
Form 10-Q
ID: 0000950170-24-058657
2024-05-13
Form 8-K
ID: 0000950170-24-058635
2024-04-30
Form 8-K
ID: 0000950170-24-050612
2024-03-13
Form 8-K
ID: 0000950170-24-030776